• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura.

作者信息

Wu T C, Yang S, Haven S, Holers V M, Lundberg A S, Wu H, Cataland S R

机构信息

Biological Science, Ohio State University, Columbus, OH, USA.

出版信息

J Thromb Haemost. 2013 Oct;11(10):1925-7. doi: 10.1111/jth.12369.

DOI:10.1111/jth.12369
PMID:23927533
Abstract
摘要

相似文献

1
Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜急性发作期间的补体激活与死亡率
J Thromb Haemost. 2013 Oct;11(10):1925-7. doi: 10.1111/jth.12369.
2
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.ADAMTS13和抗ADAMTS13抗体作为获得性血栓性血小板减少性紫癜缓解期复发的标志物。
Haematologica. 2008 Feb;93(2):232-9. doi: 10.3324/haematol.11739. Epub 2008 Jan 26.
3
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.正常个体和血栓性血小板减少性紫癜患者血浆中的ADAMTS13表型。
Eur J Pediatr. 2007 Mar;166(3):249-57. doi: 10.1007/s00431-006-0354-2. Epub 2006 Dec 24.
4
Complement activation in thrombotic thrombocytopenic purpura.补体激活在血栓性血小板减少性紫癜中的作用。
J Thromb Haemost. 2012 May;10(5):791-8. doi: 10.1111/j.1538-7836.2012.04674.x.
5
[Clinical significance of the FRETS-vWF73 assay in the patients with thrombotic thrombocytopenic purpura (TTP)].[荧光共振能量转移-血管性血友病因子73检测在血栓性血小板减少性紫癜（TTP）患者中的临床意义]
Zhonghua Xue Ye Xue Za Zhi. 2012 Sep;33(9):761-2. doi: 10.3760/cma.j.issn.0253-2727.2012.09.018.
6
Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis.酷似急性脑膜脑炎的血栓性血小板减少性紫癜
Acta Clin Belg. 2011 Jan-Feb;66(1):55-6. doi: 10.2143/ACB.66.1.2062516.
7
Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.自身免疫性血栓性血小板减少性紫癜中循环 ADAMTS13 特异性免疫复合物的测量和流行率。
J Thromb Haemost. 2014;12(3):329-36. doi: 10.1111/jth.12494.
8
Drop of residual plasmatic activity of ADAMTS13 to undetectable levels during acute disease in a patient with adult-onset congenital thrombotic thrombocytopenic purpura.在一名成年发病的先天性血栓性血小板减少性紫癜患者的急性疾病期间，ADAMTS13的残余血浆活性降至无法检测的水平。
Blood Cells Mol Dis. 2013 Jan;50(1):59-60. doi: 10.1016/j.bcmd.2012.08.001. Epub 2012 Sep 11.
9
Survival and relapse in patients with thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜患者的生存和复发。
Blood. 2010 Feb 25;115(8):1500-11; quiz 1662. doi: 10.1182/blood-2009-09-243790. Epub 2009 Dec 23.
10
ADAMTS13 activity and the risk of thrombotic thrombocytopenic purpura relapse in pregnancy.妊娠期间ADAMTS13活性与血栓性血小板减少性紫癜复发风险
Br J Haematol. 2011 Apr;153(2):277-9. doi: 10.1111/j.1365-2141.2010.08558.x. Epub 2011 Jan 31.

引用本文的文献

1
Genetic variants contribute to modulation of renal function in patients with immune thrombotic thrombocytopenic purpura.基因变异有助于调节免疫性血栓性血小板减少性紫癜患者的肾功能。
Blood Vessel Thromb Hemost. 2024 Jul 16;1(4):100019. doi: 10.1016/j.bvth.2024.100019. eCollection 2024 Dec.
2
Thrombotic Thrombocytopenic Purpura in Pediatric Patients.儿童患者的血栓性血小板减少性紫癜
Biomedicines. 2025 Apr 25;13(5):1038. doi: 10.3390/biomedicines13051038.
3
Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review.
免疫性血栓性血小板减少性紫癜：发病机制与新疗法：一篇叙述性综述
Ann Blood. 2023 Sep 30;8. doi: 10.21037/aob-22-29. Epub 2023 Jan 6.
4
Immune and Hereditary Thrombotic Thrombocytopenic Purpura: Can ADAMTS13 Deficiency Alone Explain the Different Clinical Phenotypes?免疫性和遗传性血栓性血小板减少性紫癜：仅ADAMTS13缺乏就能解释不同的临床表型吗？
J Clin Med. 2023 Apr 25;12(9):3111. doi: 10.3390/jcm12093111.
5
Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura?内皮细胞活化是血栓性血小板减少性紫癜的关键事件吗？
J Clin Med. 2023 Jan 18;12(3):758. doi: 10.3390/jcm12030758.
6
Complement Mediated Endothelial Damage in Thrombotic Microangiopathies.血栓性微血管病中补体介导的内皮损伤
Front Med (Lausanne). 2022 Apr 25;9:811504. doi: 10.3389/fmed.2022.811504. eCollection 2022.
7
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management.血栓性血小板减少性紫癜：病理生理学、诊断与管理
J Clin Med. 2021 Feb 2;10(3):536. doi: 10.3390/jcm10030536.
8
Plasma levels of S100A8/A9, histone/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura.血浆 S100A8/A9、组蛋白/DNA 复合物和游离细胞 DNA 水平预测免疫性血栓性血小板减少性紫癜的不良结局。
J Thromb Haemost. 2021 Feb;19(2):370-379. doi: 10.1111/jth.15176. Epub 2021 Jan 3.
9
The interaction between the complement system and hemostatic factors.补体系统与止血因子的相互作用。
Curr Opin Hematol. 2020 Sep;27(5):341-352. doi: 10.1097/MOH.0000000000000605.
10
Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura.ADAMTS13活性对非典型溶血尿毒综合征（aHUS）的预后评估价值以及aHUS与血栓性血小板减少性紫癜补体血清学的比较。
Blood Res. 2019 Sep;54(3):218-228. doi: 10.5045/br.2019.54.3.218. Epub 2019 Sep 25.